Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01218334 · ClinicalTrials.gov registry record
A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function
A clinical trial of Cardiac Electrical Function, sponsored by NYU Langone Health.
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT01218334: Completed study of Cardiac Electrical Function, sponsored by NYU Langone Health.
NCT01218334 is a study of Cardiac Electrical Function that has completed, run by NYU Langone Health. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01218334, a study of Cardiac Electrical Function, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is a two-arm, randomized, single-blinded, cross-over Phase III clinical trial in which patients in 3 distinct clinical scenarios will receive the 12LEG, followed by the standard ECG, or vice-versa. Each participant will then apply the Hand ECG themselves. The 3 clinical scenarios will be: 1. patients at preoperative assessment for elective cardiac catheterization or electrophysiology procedures; 2. patients coming for outpatient cardiology appointments; 3. Inpatients admitted with a cardiac diagnosis. The electrophysiologists reviewing ECGs will be blinded to the equipment utilized to obtain the ECG.
Conditions Studied
Interventions
- DEVICE 12 Lead Glove
Study Locations (1)
New York
- New York University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2008-06 |
| Est. Completion | 2012-02 |
What the finished NCT01218334 record still lists
NCT01218334 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cardiac Electrical Function appearing as the primary indexed condition, and to 1 intervention - of which 12 Lead Glove is the first listed.
NCT01218334 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01218334 about?
NCT01218334 is a clinical study titled "A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function". The proposed study is a two-arm, randomized, single-blinded, cross-over Phase III clinical trial in which patients in 3 distinct clinical scenarios will receive the 12LEG, followed by the standard ECG, or vice-versa. Each participant will then apply the Hand ECG themselves. The 3 clinical scenarios ...
What is the current status of trial NCT01218334?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2008-06. Estimated completion is 2012-02.
What conditions does trial NCT01218334 study?
This clinical trial studies the following conditions: Cardiac Electrical Function.
What interventions are being tested in trial NCT01218334?
The interventions under investigation include: 12 Lead Glove (DEVICE).
Who is sponsoring clinical trial NCT01218334?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01218334 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia